Watch out on Wednesday for this pharma stock that announced bumper Q1 results and 175 per cent dividends

The company has also announced dividends of Rs 3.5 per share that have a face value of Rs 2 per share with a record date fixed on August 22.

The shares of Natco Pharma are likely to be in high demand on Wednesday as the company has announced an extraordinary set of numbers in Q1. The PAT declared is at Rs 320 crore vs Rs 75 crore during a similar period the previous year.   

The company has also announced dividends of Rs 3.5 per share that have a face value of Rs 2 per share with a record date fixed on August 22.   

The shares of Natco Pharma have been outperforming markets in the past one month by recording gains of over 18 per cent. BSE Sensex climbed nearly 9 per cent in a similar period.   

Owing to the bumper results and the dividend announcement, the shares of Natco Pharma may remain in the limelight on Wednesday.   

The financial trend has been weak for Natco Pharma until the quarter and hence, the positive results in Q1 may attract buyers in the coming sessions.  

Hyderabad-based Natco Pharma is a multinational pharmaceutical firm in India. The business produces agricultural health science products, completed dosage formulations of active medicinal components, and contract manufacturing services.